Oscar Health, INC Form 4 insider transactions

NYSE
Oscar Health, Inc. Director William Gassen was granted 14,134 restricted stock units (RSUs) on June 4, 2025, increasing his total beneficial ownership to 74,365 Class A Common Stock shares.
NYSE
Janet Liang, President of Oscar Insurance, disposed of 7,196 shares of Oscar Health Class A Common Stock at $13.8 per share to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
Oscar Health's Chief Legal Officer, Adam McAnaney, reported the disposition of 1,847 shares of Class A Common Stock to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
Oscar Health's President of Technology & CTO, Mario Schlosser, reported the disposition of 23,879 Class A Common Stock shares to cover tax withholdings from restricted stock unit vesting, while also correcting a previous filing regarding his total beneficial ownership.
NYSE
Oscar Health's Chief Financial Officer, Richard Scott Blackley, disposed of 28,185 shares of Class A Common Stock on June 2, 2025, to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
Oscar Health's Chief Accounting Officer, Victoria Baltrus, reported the disposition of 6,265 Class A common shares to satisfy tax obligations related to restricted stock unit vesting.
NYSE
Director Elbert O. Robinson Jr. sold 25,000 shares of Oscar Health's Class A Common Stock at a weighted average price of $16.43 on May 12, 2025.
NYSE
Director David Plouffe received 1,734 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments for board service.
NYSE
Director William Gassen received 1,530 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments.
NYSE
Director Jeffery H. Boyd acquired 4,285 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments.
NYSE
Mark Bertolini, CEO of Oscar Health, reports the vesting of restricted stock units resulting in the issuance of Class A Common Stock.
NYSE
Victoria Baltrus, Chief Accounting Officer of Oscar Health, Inc., reported the acquisition of 10,611 restricted stock units (RSUs) on March 5, 2025, according to a Form 4 filing with the SEC.
NYSE
Mario Schlosser, President of Technology & CTO at Oscar Health, reports the acquisition of restricted stock units and an adjustment to his holdings of Class A Common Stock.
NYSE
Richard Scott Blackley, CFO of Oscar Health, reports the acquisition of 103,426 shares of Class A Common Stock on March 5, 2025, bringing his total holdings to 1,432,520 shares.
NYSE
Janet Liang, President of Oscar Insurance, reported the vesting of restricted stock units in Oscar Health, Inc.
NYSE
Adam McAnaney, Chief Legal Officer of Oscar Health, Inc., reports the acquisition of restricted stock units (RSUs) and updates to his beneficial ownership of Class A Common Stock.
NYSE
Mario Schlosser, President of Technology & CTO of Oscar Health, Inc., disposed of shares to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Richard Scott Blackley, CFO of Oscar Health, Inc., disposed of 22,428 shares of Class A Common Stock on March 1, 2025, to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Victoria Baltrus, Chief Accounting Officer of Oscar Health, Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NYSE
Adam McAnaney, Chief Legal Officer of Oscar Health, reports the acquisition of stock options and restricted stock units.
NYSE
Janet Liang, President of Oscar Insurance, reports the acquisition of restricted stock units and stock options in Oscar Health, Inc.
NYSE
Director Sid Sankaran reports a gift of Oscar Health Class A Common Stock, both acquired and disposed of, on February 7, 2025.
NYSE
Oscar Health director Jeffery H. Boyd acquired 2,043 deferred stock units in lieu of cash compensation for board service.
NYSE
Alessandrea C. Quane, EVP and Chief Insurance Officer at Oscar Health, sold shares to cover tax obligations after restricted stock units vested.
NYSE
Oscar Health's Chief Financial Officer, Richard Scott Blackley, sold a portion of his Class A common stock after the vesting of restricted stock units.
NYSE
Oscar Health's Chief Operating Officer, Steven Wolin, engaged in multiple transactions involving Class A common stock, including the vesting of restricted stock units and subsequent sales to cover tax obligations.
NYSE
Oscar Health's President of Technology & CTO, Mario Schlosser, sold shares to cover tax obligations after restricted stock units vested.
NYSE
Ranmali Bopitiya, EVP & Chief Legal Officer at Oscar Health, sold shares to cover tax obligations following the vesting of restricted stock units.
NYSE
An Oscar Health executive, Alessandrea C. Quane, sold a portion of her Class A common stock after the vesting of restricted stock units, according to a recent SEC filing.
NYSE
Oscar Health's Chief Financial Officer, Richard Blackley, sold a portion of his Class A common stock following the vesting of restricted stock units.